Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity

Normal tissue reactions vary significantly among patients receiving the same radiation treatment regimen, reflecting the multifactorial etiology of late radiation toxicity. Predicting late radiation toxicity is crucial, as it aids in the initial decision-making process regarding the treatment modali...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna C. Nuijens, Arlene L. Oei, Nicolaas A. P. Franken, Coen R. N. Rasch, Lukas J. A. Stalpers
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/32/1/47
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588731016544256
author Anna C. Nuijens
Arlene L. Oei
Nicolaas A. P. Franken
Coen R. N. Rasch
Lukas J. A. Stalpers
author_facet Anna C. Nuijens
Arlene L. Oei
Nicolaas A. P. Franken
Coen R. N. Rasch
Lukas J. A. Stalpers
author_sort Anna C. Nuijens
collection DOAJ
description Normal tissue reactions vary significantly among patients receiving the same radiation treatment regimen, reflecting the multifactorial etiology of late radiation toxicity. Predicting late radiation toxicity is crucial, as it aids in the initial decision-making process regarding the treatment modalities. For patients undergoing radiotherapy, anticipating late toxicity allows for planning adjustments to optimize individualized care. Various dosimetric parameters have been shown to influence the incidence of late toxicity, and the literature available on this topic is extensive. This narrative review examines patient-related determinants of late toxicity following external beam radiotherapy for pelvic tumors, with a focus on prostate and cervical cancer patients. In Part I, we address various methods for quantifying radiation toxicity, providing context for interpreting toxicity data. Part II examines the current insights into the clinical risk factors for late toxicity. While certain factors—such as previous abdominal surgery, smoking behavior, and severe acute toxicity—have consistently been reported, most of the others show inconsistent associations. In Part III, we explore the influence of genetic factors and discuss promising predictive assays. Single-nucleotide polymorphisms (SNPs) likely elevate the risk in specific combinations. Advances in artificial intelligence now allow for the identification of SNP patterns from large datasets, supporting the development of polygenic risk scores. These innovations hold promise for improving personalized treatment strategies and reducing the burden of late toxicity in cancer survivors.
format Article
id doaj-art-d8456b80dea24096acb0e41c756146d1
institution Kabale University
issn 1198-0052
1718-7729
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj-art-d8456b80dea24096acb0e41c756146d12025-01-24T13:28:29ZengMDPI AGCurrent Oncology1198-00521718-77292025-01-013214710.3390/curroncol32010047Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation ToxicityAnna C. Nuijens0Arlene L. Oei1Nicolaas A. P. Franken2Coen R. N. Rasch3Lukas J. A. Stalpers4Department of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Meibergdreef, 1105 AZ Amsterdam, The NetherlandsDepartment of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Meibergdreef, 1105 AZ Amsterdam, The NetherlandsDepartment of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Meibergdreef, 1105 AZ Amsterdam, The NetherlandsDepartment of Radiation Oncology, Leiden University Medical Center, Albinusdreef, 2333 ZA Leiden, The NetherlandsDepartment of Radiation Oncology, Amsterdam UMC Location University of Amsterdam, Meibergdreef, 1105 AZ Amsterdam, The NetherlandsNormal tissue reactions vary significantly among patients receiving the same radiation treatment regimen, reflecting the multifactorial etiology of late radiation toxicity. Predicting late radiation toxicity is crucial, as it aids in the initial decision-making process regarding the treatment modalities. For patients undergoing radiotherapy, anticipating late toxicity allows for planning adjustments to optimize individualized care. Various dosimetric parameters have been shown to influence the incidence of late toxicity, and the literature available on this topic is extensive. This narrative review examines patient-related determinants of late toxicity following external beam radiotherapy for pelvic tumors, with a focus on prostate and cervical cancer patients. In Part I, we address various methods for quantifying radiation toxicity, providing context for interpreting toxicity data. Part II examines the current insights into the clinical risk factors for late toxicity. While certain factors—such as previous abdominal surgery, smoking behavior, and severe acute toxicity—have consistently been reported, most of the others show inconsistent associations. In Part III, we explore the influence of genetic factors and discuss promising predictive assays. Single-nucleotide polymorphisms (SNPs) likely elevate the risk in specific combinations. Advances in artificial intelligence now allow for the identification of SNP patterns from large datasets, supporting the development of polygenic risk scores. These innovations hold promise for improving personalized treatment strategies and reducing the burden of late toxicity in cancer survivors.https://www.mdpi.com/1718-7729/32/1/47external beam radiotherapylate radiation toxicityquality of lifegenetic predispositionbiomarkerspredictive factors
spellingShingle Anna C. Nuijens
Arlene L. Oei
Nicolaas A. P. Franken
Coen R. N. Rasch
Lukas J. A. Stalpers
Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity
Current Oncology
external beam radiotherapy
late radiation toxicity
quality of life
genetic predisposition
biomarkers
predictive factors
title Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity
title_full Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity
title_fullStr Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity
title_full_unstemmed Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity
title_short Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity
title_sort towards personalized radiotherapy in pelvic cancer patient related risk factors for late radiation toxicity
topic external beam radiotherapy
late radiation toxicity
quality of life
genetic predisposition
biomarkers
predictive factors
url https://www.mdpi.com/1718-7729/32/1/47
work_keys_str_mv AT annacnuijens towardspersonalizedradiotherapyinpelviccancerpatientrelatedriskfactorsforlateradiationtoxicity
AT arleneloei towardspersonalizedradiotherapyinpelviccancerpatientrelatedriskfactorsforlateradiationtoxicity
AT nicolaasapfranken towardspersonalizedradiotherapyinpelviccancerpatientrelatedriskfactorsforlateradiationtoxicity
AT coenrnrasch towardspersonalizedradiotherapyinpelviccancerpatientrelatedriskfactorsforlateradiationtoxicity
AT lukasjastalpers towardspersonalizedradiotherapyinpelviccancerpatientrelatedriskfactorsforlateradiationtoxicity